×

Marathon Pharma delays launch of drug amid criticism

4:28 PM ET Mon, 13 Feb 2017

Marathon Pharmaceuticals delays the launch of their $89,000 muscular dystrophy drug amid drug pricing concerns. CNBC's Meg Tirrell reports.